{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:37:10Z","timestamp":1791466630433,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100009010","name":"Novartis Pharmaceuticals UK Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s40744-021-00380-2","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T18:46:29Z","timestamp":1633632389000},"page":"1775-1787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis"],"prefix":"10.1007","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct01358175","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01649375","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02008916","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02159053","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02896127","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8086-9915","authenticated-orcid":false,"given":"Irene","family":"van der Horst-Bruinsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Miceli-Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Marzo-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Kivitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effie","family":"Pournara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"issue":"9783","key":"380_CR1","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D. Spondyloarthritis. Lancet (London, England). 2011;377(9783):2127\u201337.","journal-title":"Lancet (London, England)"},{"issue":"5","key":"380_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.berh.2014.10.007","volume":"28","author":"N Garg","year":"2014","unstructured":"Garg N, van den Bosch F, Deodhar A. The concept of spondyloarthritis: where are we now? Best Pract Res Clin Rheumatol. 2014;28(5):663\u201372.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"380_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-018-0744-2","volume":"20","author":"T Rusman","year":"2018","unstructured":"Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE. Gender differences in axial spondyloarthritis: women are not so lucky. Curr Rheumatol Rep. 2018;20(6):35.","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl 2","key":"380_CR4","first-page":"929","volume":"76","author":"H Baumberger","year":"2017","unstructured":"Baumberger H, Khan M. SAT0417 Gradual progressive change to equal prevalence of ankylosing spondylitis among males and females in switzerland: data from the swiss ankylosing spondylitis society (SVMB). Ann Rheum Dis. 2017;76(Suppl 2):929.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"380_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000592","volume":"3","author":"H Marzo-Ortega","year":"2017","unstructured":"Marzo-Ortega H, Sieper J, Kivitz A, Blanco R, Cohen M, Delicha E-M, et al. Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2. RMD Open. 2017;3(2): e000592.","journal-title":"RMD Open"},{"issue":"1","key":"380_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13075-017-1490-y","volume":"19","author":"K Pavelka","year":"2017","unstructured":"Pavelka K, Kivitz A, Dokoupilova E, Blanco R, Maradiaga M, Tahir H, et al. Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: A randomized, double-blind phase 3 study, MEASURE 3. Arthritis Res Ther. 2017;19(1):285.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"380_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006634","volume":"4","author":"NN Haroon","year":"2014","unstructured":"Haroon NN, Paterson JM, Li P, Haroon N. Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of AS. BMJ Open. 2014;4(12): e006634.","journal-title":"BMJ Open"},{"issue":"4","key":"380_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/1756-185X.13271","volume":"21","author":"T Rusman","year":"2018","unstructured":"Rusman T, Ten Wolde S, Euser SM, van der Ploeg T, van Hall O, van der Horst-Bruinsma IE. Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice. Int J Rheum Dis. 2018;21(4):836\u201342.","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"380_CR9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/annrheumdis-2012-202431","volume":"72","author":"IE van der Horst-Bruinsma","year":"2013","unstructured":"van der Horst-Bruinsma IE, Zack DJ, Szumski A, Koenig AS. Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies. Ann Rheum Dis. 2013;72(7):1221\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"380_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3899\/jrheum.170166","volume":"45","author":"M Hebeisen","year":"2018","unstructured":"Hebeisen M, Neuenschwander R, Scherer A, Exer P, Weber U, Tamborrini G, et al. Response to tumor necrosis factor inhibition in male and female patients with ankylosing spondylitis: data from a Swiss cohort. J Rheumatol. 2018;45(4):506\u201312.","journal-title":"J Rheumatol"},{"issue":"5","key":"380_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/ard.2006.060293","volume":"66","author":"W Lee","year":"2007","unstructured":"Lee W, Reveille JD, Davis JC Jr, Learch TJ, Ward MM, Weisman MH. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis. 2007;66(5):633\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"26","key":"380_CR12","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, et al. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. N Engl J Med. 2015;373(26):2534\u201348.","journal-title":"N Engl J Med"},{"issue":"1","key":"380_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204322","volume":"73","author":"E Feldtkeller","year":"2014","unstructured":"Feldtkeller E, Lind-Albrecht G. Impact of gender on outcomes in ankylosing spondylitis. Ann Rheum Dis. 2014;73(1): e2-e.","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"380_CR14","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1097\/CM9.0000000000001099","volume":"133","author":"F Huang","year":"2020","unstructured":"Huang F, Sun F, Wan WG, Wu LJ, Dong LL, Zhang X, et al. Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5. Chin Med J. 2020;133(21):2521\u201331.","journal-title":"Chin Med J"},{"issue":"2","key":"380_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40744-018-0123-5","volume":"5","author":"AJ Kivitz","year":"2018","unstructured":"Kivitz AJ, Wagner U, Dokoupilova E, Supronik J, Martin R, Talloczy Z, et al. Efficacy and safety of secukinumab 150 mg with and without loading regimen in ankylosing spondylitis: 104-week results from MEASURE 4 study. Rheumatol Ther. 2018;5(2):447\u201362.","journal-title":"Rheumatol Ther"},{"key":"380_CR16","doi-asserted-by":"publisher","unstructured":"Glintborg B, Lindstrom U, Di Giuseppe D, et al. Arthritis Care Res (Hoboken). 2020. doi: https:\/\/doi.org\/10.1002\/acr.24523(Epub ahead of print).","DOI":"10.1002\/acr.24523"},{"issue":"9","key":"380_CR17","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1136\/annrheumdis-2019-215934","volume":"79","author":"R Micheroli","year":"2020","unstructured":"Micheroli R, Tellenbach C, Scherer A, B\u00fcrki K, Niederman K, Nissen MJ, et al. Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2020;79(9):1203\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"380_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/art.39464","volume":"68","author":"E Gracey","year":"2016","unstructured":"Gracey E, Yao Y, Green B, Qaiyum Z, Baglaenko Y, Lin A, et al. Sexual dimorphism in the Th17 signature of ankylosing spondylitis. Arthritis Rheumatol. 2016;68(3):679\u201389.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"380_CR19","first-page":"2389","volume":"25","author":"EJ Giltay","year":"1998","unstructured":"Giltay EJ, Popp-Snijders C, van Schaardenburg D, Dekker-Saeys BJ, Gooren LJ, Dijkmans BA. Serum testosterone levels are not elevated in patients with ankylosing spondylitis. J Rheumatol. 1998;25(12):2389\u201394.","journal-title":"J Rheumatol"},{"key":"380_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1749-6632.1999.tb07658.x","volume":"876","author":"EJ Giltay","year":"1999","unstructured":"Giltay EJ, van Schaardenburg D, Gooren LJ, Popp-Snijders C, Dijkmans BA. Androgens and ankylosing spondylitis: a role in the pathogenesis? Ann N Y Acad Sci. 1999;876:340\u201364 (discussion 65).","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"380_CR21","first-page":"497","volume":"17","author":"FJ Jimenez-Balderas","year":"1990","unstructured":"Jimenez-Balderas FJ, Tapia-Serrano R, Madero-Cervera JI, Murrieta S, Mintz G. Ovarian function studies in active ankylosing spondylitis in women. Clinical response to estrogen therapy. J Rheumatol. 1990;17(4):497\u2013502.","journal-title":"J Rheumatol"},{"issue":"7","key":"380_CR22","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3899\/jrheum.130996","volume":"41","author":"D Mahendira","year":"2014","unstructured":"Mahendira D, Thavaneswaran A, Carty A, Haroon N, Anton A, Passalent L, et al. Analysis of the effect of the oral contraceptive pill on clinical outcomes in women with ankylosing spondylitis. J Rheumatol. 2014;41(7):1344\u20138.","journal-title":"J Rheumatol"},{"issue":"3","key":"380_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/art.23321","volume":"59","author":"W Lee","year":"2008","unstructured":"Lee W, Reveille JD, Weisman MH. Women with ankylosing spondylitis: a review. Arthritis Rheumatol. 2008;59(3):449\u201354.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"380_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/nri2394","volume":"8","author":"EN Fish","year":"2008","unstructured":"Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008;8(9):737\u201344.","journal-title":"Nat Rev Immunol"},{"key":"380_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.phrs.2017.04.027","volume":"121","author":"C Tannenbaum","year":"2017","unstructured":"Tannenbaum C, Day D. Age and sex in drug development and testing for adults. Pharmacol Res. 2017;121:83\u201393.","journal-title":"Pharmacol Res"},{"issue":"11","key":"380_CR26","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1136\/ard.2009.124446","volume":"69","author":"B Glintborg","year":"2010","unstructured":"Glintborg B, Ostergaard M, Krogh NS, Dreyer L, Kristensen HL, Hetland ML. Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years\u2019 surveillance in the Danish nationwide DANBIO registry. Ann Rheum Dis. 2010;69(11):2002\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"380_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/rheumatology\/ket433","volume":"53","author":"E Gremese","year":"2014","unstructured":"Gremese E, Bernardi S, Bonazza S, Nowik M, Peluso G, Massara A, et al. Body weight, gender and response to TNF-\u03b1 blockers in axial spondyloarthritis. Rheumatology (Oxford). 2014;53(5):875\u201381.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"380_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3109\/03009742.2014.918173","volume":"43","author":"A Gulfe","year":"2014","unstructured":"Gulfe A, Kapetanovic MC, Kristensen LE. Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with non-radiographic axial spondyloarthritis: an observational cohort study from Southern Sweden. Scand J Rheumatol. 2014;43(6):493\u20137.","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"380_CR29","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","volume":"65","author":"N Haroon","year":"2013","unstructured":"Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, et al. The impact of tumor necrosis factor \u03b1 inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheumatol. 2013;65(10):2645\u201354.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"380_CR30","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/acr.20258","volume":"62","author":"LE Kristensen","year":"2010","unstructured":"Kristensen LE, Karlsson JA, Englund M, Petersson IF, Saxne T, Geborek P. Presence of peripheral arthritis and male sex predicting continuation of anti-tumor necrosis factor therapy in ankylosing spondylitis: an observational prospective cohort study from the South Swedish Arthritis Treatment Group Register. Arthritis Care Res. 2010;62(10):1362\u20139.","journal-title":"Arthritis Care Res"},{"key":"380_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12891-015-0620-4","volume":"16","author":"M Lorenzin","year":"2015","unstructured":"Lorenzin M, Ortolan A, Frallonardo P, Oliviero F, Punzi L, Ramonda R. Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab. BMC Musculoskelet Disord. 2015;16:166.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"380_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3899\/jrheum.17666","volume":"45","author":"E Lubrano","year":"2018","unstructured":"Lubrano E, Perrotta FM, Manara M, D\u2019Angelo S, Addimanda O, Ramonda R, et al. The sex influence on response to tumor necrosis factor-\u03b1 inhibitors and remission in axial spondyloarthritis. J Rheumatol. 2018;45(2):195\u2013201.","journal-title":"J Rheumatol"},{"issue":"7","key":"380_CR33","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3899\/jrheum.111337","volume":"39","author":"J Paccou","year":"2012","unstructured":"Paccou J, Bacl\u00e9-Boutry MA, Solau-Gervais E, Bele-Philippe P, Flipo RM. Dosage adjustment of anti-tumor necrosis factor-\u03b1 inhibitor in ankylosing spondylitis is effective in maintaining remission in clinical practice. J Rheumatol. 2012;39(7):1418\u201323.","journal-title":"J Rheumatol"},{"issue":"6","key":"380_CR34","first-page":"958","volume":"27","author":"K Pavelka","year":"2009","unstructured":"Pavelka K, Forejtov\u00e1 S, Stolfa J, Chroust K, Buresov\u00e1 L, Mann H, et al. Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA. Clin Exp Rheumatol. 2009;27(6):958\u201363.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"380_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13075-018-1665-1","volume":"20","author":"AKE Deminger","year":"2018","unstructured":"Deminger AKE, Geijer M, G\u00f6thlin J, Hedberg M, Rehnberg E, et al. A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis. Arthritis Res Ther. 2018;20(1):162.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"380_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13075-018-1705-x","volume":"20","author":"A Ortolan","year":"2018","unstructured":"Ortolan A, van Lunteren M, Ramiro S, Ramonda R, Landew\u00e9 RBM, Dagfinrud H, et al. Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort. Arthritis Res Ther. 2018;20(1):218.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"380_CR37","first-page":"419","volume":"55","author":"C Webers","year":"2016","unstructured":"Webers C, Essers I, Ramiro S, Stolwijk C, Landew\u00e9 R, van der Heijde D, et al. Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study. Rheumatology (Oxford). 2016;55(3):419\u201328.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"380_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4103\/0975-2870.128977","volume":"7","author":"A Amiri","year":"2014","unstructured":"Amiri A, Sedighi O. Prevalence of fibromyalgia in patients with ankylosing spondylitis. Med J Dr DY Patil Univ. 2014;7(3):338\u201341.","journal-title":"Med J Dr DY Patil Univ"},{"issue":"6","key":"380_CR39","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R, Baraliakos X, Van den Bosch F, Sepriano A, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978\u201391.","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00380-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-021-00380-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00380-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T13:12:33Z","timestamp":1699621953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-021-00380-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1007\/s40744-021-00380-2","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"assertion":[{"value":"11 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}